tiprankstipranks
Trending News
More News >
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
Advertisement

Crinetics Pharmaceuticals (CRNX) Ratios

Compare
568 Followers

Crinetics Pharmaceuticals Ratios

CRNX's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, CRNX's free cash flow was decreased by $ and operating cash flow was $-308.60. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
22.53 13.07 12.45 21.55 16.92
Quick Ratio
22.53 13.07 12.45 21.05 17.10
Cash Ratio
1.65 1.25 1.18 12.55 8.87
Solvency Ratio
-3.03 -2.22 -4.42 -5.53 -4.93
Operating Cash Flow Ratio
-4.56 -3.78 -4.16 -5.54 -5.91
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 1.18B$ 477.91M$ 309.34M$ 325.65M$ 162.97M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.08 <0.01 <0.01 0.02
Debt-to-Equity Ratio
0.04 0.10 >-0.01 -0.01 -0.02
Debt-to-Capital Ratio
0.04 0.09 >-0.01 -0.01 -0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.18 -0.80 -1.28 -1.09
Debt Service Coverage Ratio
0.00 0.00 -37.74 0.00 0.00
Interest Coverage Ratio
0.00 0.00 -38.89 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.55 0.89 0.12 0.08 0.13
Net Debt to EBITDA
0.12 0.01 0.18 1.85 1.23
Profitability Margins
Gross Profit Margin
0.92%100.00%70.68%-17.07%-80178.87%
EBIT Margin
-47707.89%-5547.17%-3544.06%-9990.91%-105567.61%
EBITDA Margin
-49143.95%-5519.81%-3523.31%-9905.38%-102233.80%
Operating Profit Margin
-49569.74%-5547.17%-3544.06%-9990.91%-105567.61%
Pretax Profit Margin
-43191.05%-5345.85%-3460.38%-9985.25%-103960.56%
Net Profit Margin
-43191.05%-5345.85%-3376.69%-9899.72%-102625.35%
Continuous Operations Profit Margin
-43191.05%-5345.85%-3460.38%-9985.25%-103960.56%
Net Income Per EBT
100.00%100.00%97.58%99.14%98.72%
EBT Per EBIT
87.13%96.37%97.64%99.94%98.48%
Return on Assets (ROA)
-24.11%-33.77%-45.42%-30.40%-39.72%
Return on Equity (ROE)
-30.95%-39.79%36.42%38.77%43.47%
Return on Capital Employed (ROCE)
-28.89%-37.64%-51.74%-32.15%-43.34%
Return on Invested Capital (ROIC)
-28.74%-37.38%-50.33%-31.87%-42.78%
Return on Tangible Assets
-24.11%-33.77%-45.42%-30.40%-39.72%
Earnings Yield
-11.08%-10.38%-16.81%-9.77%-16.96%
Efficiency Ratios
Receivables Turnover
0.00 0.43 0.00 0.53 0.04
Payables Turnover
0.16 0.00 0.20 0.37 16.34
Inventory Turnover
0.00 0.00 0.00 0.16 -31.10
Fixed Asset Turnover
0.01 0.07 0.95 0.23 0.01
Asset Turnover
<0.01 <0.01 0.01 <0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 0.01 <0.01 <0.01
Cash Conversion Cycle
-2.33K 850.51 -1.81K 2.03K 9.39K
Days of Sales Outstanding
0.00 850.51 0.00 687.00 9.42K
Days of Inventory Outstanding
0.00 0.00 0.00 2.33K -11.74
Days of Payables Outstanding
2.33K 0.00 1.81K 989.72 22.34
Operating Cycle
0.00 850.51 0.00 3.02K 9.41K
Cash Flow Ratios
Operating Cash Flow Per Share
-2.81 -2.86 -2.22 -2.30 -2.04
Free Cash Flow Per Share
-2.85 -2.94 -2.25 -2.32 -2.04
CapEx Per Share
0.04 0.08 0.03 0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.03 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-69.73 -35.48 -69.57 -203.18 -333.48
Capital Expenditure Coverage Ratio
-69.73 -35.48 -69.57 -203.18 -333.48
Operating Cash Flow Coverage Ratio
-5.15 -3.22 -56.92 -28.82 -15.45
Operating Cash Flow to Sales Ratio
-344.17 -41.44 -24.32 -82.18 -873.62
Free Cash Flow Yield
-8.90%-8.28%-12.28%-8.15%-14.48%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.95 -9.63 -5.95 -10.23 -5.90
Price-to-Sales (P/S) Ratio
3.89K 514.87 200.82 1.01K 6.05K
Price-to-Book (P/B) Ratio
2.34 3.83 -2.17 -3.97 -2.56
Price-to-Free Cash Flow (P/FCF) Ratio
-11.14 -12.08 -8.14 -12.27 -6.91
Price-to-Operating Cash Flow Ratio
-11.23 -12.42 -8.26 -12.33 -6.93
Price-to-Earnings Growth (PEG) Ratio
3.02 -0.49 -0.55 -0.63 -0.36
Price-to-Fair Value
2.34 3.83 -2.17 -3.97 -2.56
Enterprise Value Multiple
-7.80 -9.31 -5.52 -8.38 -4.69
Enterprise Value
2.94B 2.06B 920.62M 894.35M 340.55M
EV to EBITDA
-7.87 -9.31 -5.52 -8.38 -4.69
EV to Sales
3.87K 514.08 194.35 829.63 4.80K
EV to Free Cash Flow
-11.07 -12.06 -7.88 -10.05 -5.47
EV to Operating Cash Flow
-11.23 -12.40 -7.99 -10.10 -5.49
Tangible Book Value Per Share
13.47 9.28 6.09 8.64 5.55
Shareholders’ Equity Per Share
13.47 9.28 -8.45 -7.16 -5.50
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.02 <0.01 0.01
Revenue Per Share
<0.01 0.07 0.09 0.03 <0.01
Net Income Per Share
-3.53 -3.69 -3.08 -2.78 -2.39
Tax Burden
1.00 1.00 0.98 0.99 0.99
Interest Burden
0.91 0.96 0.98 1.00 0.98
Research & Development to Revenue
346.13 42.00 27.49 78.16 802.79
SG&A to Revenue
150.57 14.48 8.95 22.75 253.89
Stock-Based Compensation to Revenue
100.54 10.20 5.97 16.10 146.86
Income Quality
0.80 0.78 0.70 0.82 0.84
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis